-
2023Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral, and T cell stimulation reveals new immune networks, iScience, 2023, 26 (8), pp.107422. ⟨10.1016/j.isci.2023.107422⟩.
-
2023Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells, Cancer Immunology, Immunotherapy, In press, ⟨10.1007/s00262-023-03486-4⟩.
-
2023Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response., PLoS Pathog 2023 Feb; 19(2): e1011170.
-
2022Les virus au service de la santé : la vaccination Viruses to rescue health: Vaccination, Médecine/Sciences, 2022, 38 (12), pp.1052-1060. ⟨10.1051/medsci/2022168⟩.
-
2022Respiratory Syncytial Virus NS1 Protein Targets the Transactivator Binding Domain of MED25, Journal of Molecular Biology, 2022, 434 (19), pp.167763. ⟨10.1016/j.jmb.2022.167763⟩.
-
2022Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1, iScience, 2022, 25 (7), pp.104599. ⟨10.1016/j.isci.2022.104599⟩.
-
2022The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies, Proceedings of the National Academy of Sciences of the United States of America, 2022, 119 (21), pp.349-363. ⟨10.1073/pnas.2200413119⟩.
-
2022Rhesus negative males have an enhanced IFNγ-mediated immune response to influenza A virus, Genes and Immunity, 2022, ⟨10.1038/s41435-022-00169-5⟩.
-
2021sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs, RNA, 2021, 28 (3), pp.277-289. ⟨10.1261/rna.078969.121⟩.
-
2021A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters, Nature Communications, 2021, 12 (1), pp.6277. ⟨10.1038/s41467-021-26506-2⟩.
-
2021HIV-1 hijacks the cell extracellular matrix to spread collectively and efficiently between T lymphocytes, 2021.
-
2021Discovery of genes that modulate flavivirus replication in an interferon-dependent manner, Journal of Molecular Biology, 2021, pp.167277. ⟨10.1016/j.jmb.2021.167277⟩.
-
2021Proteomic Analysis Uncovers Measles Virus Protein C Interaction With p65–iASPP Protein Complex, Molecular and Cellular Proteomics, 2021, 20, pp.100049. ⟨10.1016/j.mcpro.2021.100049⟩.
-
2020Retinoic Acid Inducible Gene I and Protein Kinase R, but Not Stress Granules, Mediate the Proinflammatory Response to Yellow Fever Virus, Journal of Virology, 2020, 94 (22), pp.e00403-20. ⟨10.1128/JVI.00403-20⟩.
-
2020Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus, Journal of Thoracic Oncology, 2020, S1556-0864(20)30019-8, Epub ahead of print. ⟨10.1016/j.jtho.2019.12.128⟩.
-
2020Reply to: Oncolytic Viral Therapy for Malignant Pleural Mesothelioma, Journal of Thoracic Oncology, 2020, ⟨10.1016/j.jtho.2020.04.011⟩.
-
2019Evaluation of the Antiviral Activity of Sephin1 Treatment and Its Consequences on eIF2α Phosphorylation in Response to Viral Infections, Frontiers in Immunology, 2019, 10, pp.134. ⟨10.3389/fimmu.2019.00134⟩.
-
2015Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial, Lancet Infect Dis 2015 Nov;15(11):1283-91.
-
2015Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes, Vaccine 2015 Aug;33(36):4548-53.
-
2015HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase, J. Hepatol. 2015 Nov;63(5):1093-102.
-
2015Towards an HBV cure: state-of-the-art and unresolved questions–report of the ANRS workshop on HBV cure, Gut 2015 Aug;64(8):1314-26.
-
2015Minicircle: Next Generation DNA Vectors for Vaccination, Methods Mol. Biol. 2015;1317:327-39.
-
2014Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?, Med. Microbiol. Immunol. 2015 Feb;204(1):121-9.
-
2014TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice, Gut 2014 Nov;.
-
2014Human hematopoietic reconstitution and HLA-restricted responses in nonpermissive alymphoid mice, J. Immunol. 2014 Aug;193(3):1504-11.
-
2014Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli., Immunity, 2014, 40 (3), pp.436-50. ⟨10.1016/j.immuni.2014.03.002⟩.
-
2014Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection, PLoS ONE 2014;9(3):e92140.
-
2014In Vitro Activities of Dermaseptins K4S4 and K4K20S4 against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa Planktonic Growth and Biofilm Formation, Antimicrobial Agents and Chemotherapy, 2014, 58 (4), pp.2221 - 2228. ⟨10.1128/AAC.02142-13⟩.
-
2014Large-Scale Nucleotide Optimization of Simian Immunodeficiency Virus Reduces Its Capacity To Stimulate Type I Interferon In Vitro, Journal of Virology, 2014, 88 (8), pp.1-27. ⟨10.1128/JVI.03223-13⟩.
-
2013Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection, J. Virol. 2014 Mar;88(5):3004-15.
-
2013Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules, J. Virol. 2013 May;87(10):5554-63.
-
2012Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model, Virology 2012 Aug;430(1):10-9.
-
2011Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice, J. Virol. 2011 Oct;85(19):10201-12.
-
2011Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges, J. Hepatol. 2011 Jun;54(6):1286-96.
-
2010Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+ T cells in vivo, Vaccine 2010 May;28(22):3818-26.
-
2010Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination, PLoS ONE 2010 Jan;5(1):e8761.
-
2009ViralORFeome: an integrated database to generate a versatile collection of viral ORFs., Nucleic Acids Research, 2010, 38 (Issue suppl1: Database issue), pp.D371-8. ⟨10.1093/nar/gkp1000⟩.
-
2009Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models, Hepatology 2009 Nov;50(5):1380-91.
-
2009Sequence analysis of the large (L) polymerase gene and trailer of the peste des petits ruminants virus vaccine strain Nigeria 75/1: expression and use of the L protein in reverse genetics., Virus Research, 2009, 145 (1), pp.9-17. ⟨10.1016/j.virusres.2009.06.002⟩.
-
2007Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients, J. Virol. 2007 May;81(10):4963-72.
-
2006Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects, Microbes Infect. 2006 Oct;8(12-13):2783-90.
-
2005Therapeutic vaccination against chronic hepatitis B virus infection, J. Clin. Virol. 2005 Dec;34 Suppl 1:S108-14.
-
2005Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers, Vaccine 2006 May;24(21):4482-9.
-
2005Loss of reactivity of vaccine-induced CD4 T cells in immunized monkeys after SIV/HIV challenge, AIDS 2005 May;19(8):757-65.
-
2005[Therapeutic vaccination against chronic hepatitis B virus infection], Therapie 2005 May-Jun;60(3):257-65.
-
2005In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus, Microbes Infect. 2005 Apr;7(4):626-34.
-
2005In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice, Immunobiology 2005;210(5):305-19.
-
2004A chimeric human T cell leukemia virus type I bearing a deltaR Moloney-murine leukemia virus envelope infects mice persistently and induces humoral and cellular immune responses., Journal of Infectious Diseases, 2005, pp.263. ⟨10.1086/426825⟩.
-
2004A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice, Eur. J. Immunol. 2004 Nov;34(11):3060-9.
-
2004Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers, Hepatology 2004 Oct;40(4):874-82.
-
2004Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles, Vaccine 2004 Sep;22(27-28):3535-45.
-
2004Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules, Int. Immunol. 2004 Sep;16(9):1275-82.
-
2003New gene-based approaches for an AIDS vaccine, Comp. Immunol. Microbiol. Infect. Dis. 2003 Oct;26(5-6):357-72.